A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantine in patients with Parkinson's disease dementia or dementia with Lewy Bodies.

Trial Profile

A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantine in patients with Parkinson's disease dementia or dementia with Lewy Bodies.

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Sep 2013

At a glance

  • Drugs Memantine (Primary)
  • Indications Dementia; Lewy body disease; Parkinson's disease
  • Focus Registrational; Therapeutic Use
  • Sponsors Lundbeck A/S
  • Most Recent Events

    • 12 Sep 2009 Results were presented at EFNS 2009.
    • 19 Mar 2009 Status changed from active, no longer recruiting to completed, according to United Kingdom Clinical Research Network.
    • 05 Mar 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top